Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Highline Therapeutics

Highline Therapeutics
ACCEL/INCU INVESTOR TYPE
Active STATUS
2 PROFESSIONALS
3 INVESTMENTS
1 PORTFOLIO
1 EXITS
Description

Highline Therapeutics is biotechnology incubator backed by Versant Ventures. The firm aims to identify and accelerate translational research and biotech company formation. It was founded in 2016 and is based in New York, New York.

Investor Status
Actively Seeking New Investments
Year Founded
2015
Primary Investor Type
Accelerator/Incubator
Primary Office
  • 54 West 21st Street
  • Suite 408
  • New York, NY 10010
  • United States

+1 (646) 000-0000

Highline Therapeutics Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Quentis Therapeutics 22-Nov-2017 Seed Round 000 Biotechnology Product Development 00000 0000000 00.0
00000 000000000000 10-Dec-2015 00000 00000 000 Drug Discovery Out of Business 00000 0000000 00.0
00000 000000000000 000000000000 Drug Discovery Out of Business 00000 0000000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Highline Therapeutics’s full profile, request a free trial.

Highline Therapeutics Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 01-Apr-2018 000 00 00000000 Completed
To view this investor’s complete exits history, request access »

Highline Therapeutics Team (3)

Name Title Deals Funds Boards Office Contact
Info
Carlo Rizzuto Ph.D Chief Executive Officer 00 0 0 New York, NY
Joseph Vacca Ph.D Chief Scientific Officer New York, NY
Paul Sekhri Operating Partner 0 0 0 New York, NY